May 20 (Reuters) - Valeant Pharmaceuticals International Inc is in talks to buy Egyptian drugmaker Amoun Pharmaceutical Co to expand its veterinary and human medicines portfolio, Bloomberg reported, citing people familiar with the matter.
MONTREAL, May 19 (Reuters) - Valeant Pharmaceuticals International Inc's exposure to Asia's growing middle class could help lead to the quintupling of sales in that market to around $5 billion by...
BOSTON (Reuters) - Wall Street's savviest investors are picking sides on Bill Ackman's new bet on Valeant Pharmaceuticals International Inc , with BlueMountain Capital and T. Rowe Price adding money, while Viking Global Investors and Jana Partners cut stakes.
BOSTON, May 15 (Reuters) - Wall Street's savviest investors are picking sides on Bill Ackman's new bet on Valeant Pharmaceuticals International Inc, with BlueMountain Capital and T. Rowe Price adding money, while Viking Global Investors and Jana Partners cut stakes.
BRK-A/B ] to Pearson ’s Valeant [ VRX ]. The entire piece is devoted to disputing ..... cheaper than rather expensive and volatile VRX . Pg 14-15: BOE rate announcement on Monday. Euro ..... frackers ok] Ackman / Pershing Square : VRX [also see Levisohn/Pg 11 above] Gaonkar / Lone
went to the individual holdings of PRHSX. Some of my contenders were: TR 10 yr 15yr GILD 26.87% 29.71% Nope no yield VRX 30.84% 15.53% Nope no yield ALXN 40.44% 19.21% Nope no yield PCYC 42.80% 12.91% Nope no yield I could go on
based on 3-yr cash flow returns on investments [CFROI], 1-yr change in CFROI, and sales growth. Top 5: GLD, CBG, VRX , TMO, MA . Bottom 5: CVX, SHLD, APA, TCK, NEM, ABX . Cheapest 5 [lowest P/E]: AAL, UAL, TRN, PPC, PBF More later
April 29 (Reuters) - Drugmaker Valeant Pharmaceuticals International Inc raised its earnings and sales forecasts for the year on Wednesday and said its chief financial officer will step down.
April 29 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc reported a quarterly profit, compared with a year-ago loss, driven by higher demand in the United States.
F. Hoffmann-La Roche Ltd. - Novartis AG - Pfizer Inc. - Regeneron Pharmaceuticals Inc. - Valeant Pharmaceuticals International Inc. Other Prominent Vendors - Abbott Laboratories Ltd. - Alcon Laboratories Inc. - Alimera Sciences